DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndromes as Influential Pharma Players Set Foot in the MDS Landscape Las Vegas, USA, Oct. 12, 2021 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Pipeline for Myelodysplastic Syndrome as Influential Pharma Players Set Foot in the MDS Landscape ...

Global Myelodysplastic Syndrome Treatment Market to Surpass US$ 5,742.7 million by 2025 SEATTLE, Sept. 25, 2017 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the Global Myelodysplastic Syndrome Treatment Market (By drug - Azacitidine, Lenalidomide, Dacogen, Jadenu) was...